NCT06823908View on ClinicalTrials.gov

in Vitro Evaluation of the Anti-fibrotic Activity of Adipose Tissu-derived Stromal Vascular Fraction Used as a Medicinal Treatment for Scarred Vocal Folds

Not yet recruitingOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

October 31, 2027

Conditions
Vocal Cord Injuries
Interventions
OTHER

Reuse of surgical waste

Heathly donnors will be received in the plastic surgery department as part of routine care. They will be informed of the study and their surgical waste (adipose tissue) will be recovered specifically for this research.

OTHER

Reuse of biological samples

Patients included in the cellcordes 2 trial who have given their consent for the re-use of their biological samples (Stromal Vascular Fraction) in other clinical research projects, and who have been informed of the cellcordes bio study.

All Listed Sponsors
collaborator

Aix Marseille Université

OTHER

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT06823908 - in Vitro Evaluation of the Anti-fibrotic Activity of Adipose Tissu-derived Stromal Vascular Fraction Used as a Medicinal Treatment for Scarred Vocal Folds | Biotech Hunter | Biotech Hunter